Jean‐Pierre Fauvel

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Estimating Glomerular Filtration Rate

Rossini Botev, CecileCombining Acute Accent Couchoud, Jean‐Pierre Fauvel et al. · Clinical Journal of the American Society of Nephrology · 2009 · 173 citations · Full text

Medicine, Nephrology, Hemodialysis +16

Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial

Michel Azizi, Héléna Pereira, Idir Hamdidouche et al. · Circulation · 2016 · 154 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li et al. · Stroke · 2021 · 118 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Molecular configuration and glomerular size selectivity in healthy and nephrotic humans

Kristina Blouch, William M. Deen, Jean‐Pierre Fauvel et al. · American Journal of Physiology-Renal Physiology · 1997 · 101 citations

Medicine, Nephrology, Physiology +14